|
"supposed to be better" is trumpted by a large randomized trial any day of the week.
Atacicept MAY be better, but has to prove it in the clinic, not in theory. PS, I am quite log here and not bashing. ZGEN has quite a few shots on goal. The market has discounted Atac. to near 0, we still have lambda and 21, and even RecoT can justify the present market cap if EU comes in. Rating :
 (1 Rating) |
Male |
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|
|
Page
1
of about
1
First
| < Prev
| Next >
| Last
|